期刊
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
卷 31, 期 -, 页码 45-57出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.bpobgyn.2015.08.009
关键词
amniotic fluid stem cell; amniotic fluid mesenchymal stem cell; regenerative medicine; cell therapy; transplantation; tissue engineering
资金
- National Institutes of Health Research (NIHR) [RP_2014-04-046] Funding Source: National Institutes of Health Research (NIHR)
- National Institute for Health Research [RP_2014-04-046] Funding Source: researchfish
- Department of Health [RP_2014-04-046] Funding Source: Medline
Regenerative medicine has recently been established as an emerging field focussing on repair, replacement or regeneration of cells, tissues and whole organs. The significant recent advances in the field have intensified the search for novel sources of stem cells with potential for therapy. Recently, researchers have identified the amniotic fluid as an untapped source of stem cells that are multi potent, possess immunomodulatory properties and do not have the ethical and legal limitations of embryonic stem cells. Stem cells from the amniotic fluid have been shown to differentiate into cell lineages representing all three embryonic germ layers without generating tumours, which make them an ideal candidate for tissue engineering applications. In addition, their ability to engraft in injured organs and modulate immune and repair responses of host tissues suggest that transplantation of such cells may be useful for the treatment of various degenerative and inflammatory diseases affecting major tissues/organs. This review summarises the evidence on amniotic fluid cells over the past 15 years and explores the potential therapeutic applications of amniotic fluid stem cells and amniotic fluid mesenchymal stem cells. (C) 2015 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据